Human umbilical cord-derived mesenchymal stem cell therapy (Beijing First Biotechnology Development)

人脐带间充质干细胞（北京第一生物）

Report date: 2026/02/12 20:00:14

Base Information

Drug NameHuman umbilical cord-derived mesenchymal stem cell therapy (Beijing First Biotechnology Development)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing First Biotechnology Development Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing First Biotechnology Development Co Ltd
Inactive CompaniesN/A
Active IndicationsRhinitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A